Client Strategy Lead, Real World Research at McKesson

Texas, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Life SciencesIndustries

Requirements

Expertise in oncology data and insights
Ability to translate complex business needs into proposals for fit-for-purpose studies
Strong observational research and disease area expertise
Knowledge of delivery processes for real-world evidence (RWE) studies
Understanding of Ontada’s data assets, capabilities, and priorities
Familiarity with a wide breadth of research approaches, methods, and designs (e.g., comparative effectiveness research, prediction modeling, descriptive studies, qualitative interviewing, health economic assessments, regulatory grade real world studies)
Deep understanding of the company’s oncology portfolio, including potential RWE gaps
Stay updated with industry, regulatory trends, and state-of-the-science observational research methods

Responsibilities

Translate customer business needs into fit-for-purpose studies leveraging Ontada’s data assets and capabilities through proposals and sales concept memos
Engage regularly with customers to understand research goals, data needs, and challenges (e.g., support pre-sales proposals and quarterly business reviews)
Ensure proposed sales concepts are feasible and aligned with Ontada’s data and service capabilities/priorities
Leverage expertise to identify upselling and cross-selling opportunities for additional studies, products, and services
Act as the voice of the customer, leading feedback cycles to sales, data, research, product development, and management teams for improvement, innovation, and strategy
Support strategy and execution of external thought leadership dissemination; represent Ontada in select external engagements
Educate customers on leveraging Ontada solutions, including synergies across the Oncosystem and with their data systems/processes
Develop and maintain strong relationships with internal and external stakeholders built on trust and respect
Act as the scientific point of continuity for customers and delivery teams to ensure satisfaction
Work closely with Sales, Medical Office, and SMEs to identify opportunities for account expansion (e.g., amendments, follow-on studies)

Skills

Oncology Data

Real World Evidence

RWE Studies

Client Strategy

Proposal Development

Stakeholder Engagement

Business Development

Sales Strategy

Data Assets

Research Expertise

McKesson

Healthcare distribution and logistics services

About McKesson

McKesson Corporation operates in the healthcare sector, focusing on the distribution of medical products and pharmaceuticals. The company acts as a middleman, purchasing medical supplies from manufacturers and delivering them to healthcare providers, pharmacies, and hospitals. This ensures that essential medical products are available when and where they are needed, supporting the healthcare system. McKesson generates revenue by marking up the cost of the products they distribute and charging service fees for their logistics and supply chain management. They also provide technology solutions to help healthcare providers improve their operations. McKesson's goal is to enhance patient care by ensuring the timely and safe delivery of healthcare products and services.

Irving, TexasHeadquarters

1833Year Founded

$7.6MTotal Funding

IPOCompany Stage

Enterprise Software, HealthcareIndustries

Benefits

Performance Bonus

401(k) Company Match

Risks

Closure of Rogers distribution center may disrupt local supply chain operations.

Sale of Rexall and Well.ca could reduce McKesson's market share in Canada.

InspiroGene may face challenges in a competitive and regulated market.

Differentiation

McKesson acts as a key intermediary in the healthcare supply chain.

The company offers technology solutions for efficient healthcare operations management.

McKesson's InspiroGene supports commercialization of cell and gene therapies.

Upsides

Increased focus on real-world evidence benefits McKesson's investment in Atropos Health.

Rise of cell and gene therapies aligns with McKesson's InspiroGene launch.

Demand for personalized medicine boosts McKesson's technology solutions and data analytics.

Land your dream remote job 3x faster with AI

Try Jobo Free